BlockBeats News, September 29th: Jia Yueting stated in a post that Faraday Future's $30 million investment in Qualigen Therapeutics (QLGN) has more than doubled its market value. It is expected that this strategic investment will be completed this week, and the crypto flywheel is accelerating.
On September 20th, Faraday Future announced that it would strategically invest $41 million through a PIPE transaction in Qualigen Therapeutics (NASDAQ: QLGN), which will be renamed as CXC10 and transformed into a crypto and Web3 business platform. The investor lineup is strong, including not only Faraday Future and Jia Yueting personally, but also Sign, a blockchain technology company that builds on-chain public infrastructure for governments and enterprises globally, providing secure solutions ranging from digital identity verification to token distribution.